Cel Sci Corp. (NYSE: CVM)
Cel-Sci Corporation (NYSE American: CVM) is a clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases.
For information including SEC Filings please refer to: https://cel-sci.com/